ATS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Personal Folders
Right arrow Download to citation manager
Right arrow Author home page(s):
Meena Nathan
Ingeborg Friehs
Yeong-Hoon Choi
Pedro J. del Nido
Right arrow Permission Requests
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nathan, M.
Right arrow Articles by del Nido, P. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nathan, M.
Right arrow Articles by del Nido, P. J.
Related Collections
Right arrow Myocardial protection

Ann Thorac Surg 2005;79:1620-1626
© 2005 The Society of Thoracic Surgeons


Original articles: Cardiovascular

Cyclosporin A But Not FK-506 Protects Against Dopamine-Induced Apoptosis in the Stunned Heart

Meena Nathan, MDa, Ingeborg Friehs, MDa, Yeong-Hoon Choi, MDa, Douglas B. Cowan, PhDb, Hung Cao-Danh, PhDa, Francis X. McGowan, MDb, Pedro J. del Nido, MDb,*

a Department of Cardiac Surgery, Children's Hospital and Harvard Medical School, Boston, Massachusetts
b Department of Anesthesiology and Pain Medicine, Children's Hospital and Harvard Medical School, Boston, Massachusetts

Accepted for publication October 19, 2004.

* Address reprint requests to Dr del Nido, Department of Cardiac Surgery, Children's Hospital Boston, Harvard Medical School, 300 Longwood Ave, Bader 279, Boston, MA 02115 (E-mail: pedro.delnido{at}tch.harvard.edu).

BACKGROUND: Dopamine given at moderate doses for inotropy to postischemic hearts has been shown to augment myocyte apoptosis in association with elevated cytosolic calcium. We hypothesize that dopamine-mediated apoptosis occurs through calcium-induced opening of the mitochondrial permeability transition (mPT) pore. We also hypothesize that cyclosporin A (CSA), a calcineurin inhibitor known to block mPT pore opening, would prevent dopamine-induced apoptosis primarily by inhibiting pore opening (cyclophilin D binding).

METHODS: Isolated perfused rabbit hearts (n = 6/group) were subjected to 30 minutes of 37°C cardioplegic arrest followed by 120 minutes reperfusion (ischemic injury that produces < 3% infarct by triphenyl-tetrazolium chloride [TTC] staining). Four groups were studied: (1) control; (2) dopamine (10 µmol/L) postischemia (dopa); (3) dopamine+CSA (0.2 µmol/L) (CSA+D) group; (4) dopamine+FK-506 (0.2 µmol/L) (FK+D) group. Left ventricular developed pressure and oxygen consumption were measured preischemia and postischemia. Bax, caspase-3 and caspase-9, and poly-ADP-ribose polymerase (PARP) activation were measured by Western blotting. Apoptotic nuclei were quantified by terminal deoxynucleotidyl transferase-mediated dUTP nick-end labeling (TUNEL) staining.

RESULTS: Dopamine postischemia improved contractile function and heart rate and this was not affected by CSA or FK. However, TUNEL positive nuclei, Bax, caspase-3 and caspase-9 activation, and PARP cleavage were all increased in dopa and FK+D groups, but not in CSA+D.

CONCLUSIONS: Cyclosporin is effective in preventing dopamine-induced apoptosis in the postischemic heart. The mechanism is likely due to inhibition of mPT pore opening since FK-506, a potent calcineurin inhibitor that does not bind to cyclophilin, did not prevent this. Low dose cyclosporin may prove useful to prevent dopamine-induced apoptosis resulting in long-term preservation of cardiac function.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
B. G. Leshnower, S. Kanemoto, M. Matsubara, H. Sakamoto, R. Hinmon, J. H. Gorman III, and R. C. Gorman
Cyclosporine Preserves Mitochondrial Morphology After Myocardial Ischemia/Reperfusion Independent of Calcineurin Inhibition
Ann. Thorac. Surg., October 1, 2008; 86(4): 1286 - 1292.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Oka, L. Wang, W. Mi, and C. A. Caldarone
Inhibition of mitochondrial remodeling by cyclosporine A preserves myocardial performance in a neonatal rabbit model of cardioplegic arrest
J. Thorac. Cardiovasc. Surg., March 1, 2008; 135(3): 585 - 593.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
N. Oka, L. Wang, W. Mi, W. Zhu, O. Honjo, and C. A. Caldarone
Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest
J. Thorac. Cardiovasc. Surg., January 1, 2008; 135(1): 123 - 130.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
S. M. MacDonnell, H. Kubo, D. M. Harris, X. Chen, R. Berretta, M. F. Barbe, S. Kolwicz, P. O. Reger, A. Eckhart, B. F. Renna, et al.
Calcineurin inhibition normalizes beta-adrenergic responsiveness in the spontaneously hypertensive rat
Am J Physiol Heart Circ Physiol, November 1, 2007; 293(5): H3122 - H3129.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
N. Roy, I. Friehs, D. B. Cowan, D. Zurakowski, F. X. McGowan, and P. J. del Nido
Dopamine Induces Postischemic Cardiomyocyte Apoptosis In Vivo: An Effect Ameliorated by Propofol
Ann. Thorac. Surg., December 1, 2006; 82(6): 2192 - 2199.
[Abstract] [Full Text] [PDF]


Home page
J. Bacteriol.Home page
N. Gavini, S. Tungtur, and L. Pulakat
Peptidyl-Prolyl cis/trans Isomerase-Independent Functional NifH Mutant of Azotobacter vinelandii.
J. Bacteriol., August 1, 2006; 188(16): 6020 - 6025.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
ANN THORAC SURG ASIAN CARDIOVASC THORAC ANN EUR J CARDIOTHORAC SURG
J THORAC CARDIOVASC SURG ICVTS ALL CTSNet JOURNALS
Copyright © 2005 by The Society of Thoracic Surgeons.